Kaiser Permanente Center for Health Research
Portland, Oregon, 97227, United States
NCT Number: NCT00065650
The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.
Looking for future studies?
Notify Me25 year–80 year
All sexes
Interventional
Phase 2
Portland, Oregon, 97227, United States
Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 months
Time frame: 3 and 6 months
Time frame: 3 and 6 months
National Center for Complementary and Integrative Health (NCCIH)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06326047
Diabetes Mellitus, Diabetes Mellitus, Type 2
Chula Vista, California, United States
View Trial DetailsNCT06423729
Body Weight, Diabetes Mellitus
Tanta, Egypt
View Trial DetailsNCT00418522
Diabetes Mellitus, Diabetes Mellitus, Type 2
Phoenix, Arizona, United States
View Trial DetailsNCT04760626
Diabetes Mellitus, Diabetes Mellitus, Type 2
Birmingham, Alabama, United States
View Trial Details